Skip to Content

Vishnu Lekraj

Vishnu Lekraj is a senior equity analyst for Morningstar.

More From Vishnu Lekraj

Profits were pressured in the quarter, but we are reiterating our fair value estimate and no-moat rating for the managed-care organization.

The Cigna merger is on track, and we are maintaining our $92 fair value estimate and wide moat rating after a solid quarter for Express Scripts.

Disastrous quarter aside, the wide-moat firm remains in a strong long-term position within the U.S. pharmaceutical market.

More About Vishnu Lekraj

Vishnu Lekraj is a senior equity analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. He covers the healthcare services industry.

Lekraj joined Morningstar in 2008 after receiving a master’s degree in business administration from the University of Florida’s Hough Graduate School of Business. Before business school, he was a financial analyst for HSBC bank.

Lekraj holds a bachelor’s degree in finance from the Warrington College of Business Administration at the University of Florida, where he graduated summa cum laude. He is also a member of the Beta Gamma Sigma international honor society. In 2012, Lekraj ranked first in the professional services industry in the StarMine Analyst Awards, presented by the Financial Times.

Sponsor Center